Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DanCann Pharma A/S appoints Martin Vedel Ernst as new Chief Financial Officer

COPENHAGEN, Denmark, 10 May 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company appoints Martin Vedel Ernst as new Chief Financial Officer (“CFO”).DanCann Pharma is currently undergoing a change from being an ambitious project to a growth company in operation. Therefore, the Company has recently upgraded significantly with key people both in the Board of Directors and in the Executive Management team. In the future, DanCann Pharma's financial tasks will be handled by Martin Vedel Ernst.

Publication of Biohit Oyj Renumeration Report 2021

Biohit Oyj Renumeration Report May 10, at 11.00 am local time (EET) Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/. Additional information:  CEO Päivi Siltala, Biohit Oyjtel. +358 9 773 861investor.relations@biohit.fiwww.biohit.fi Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce

Invitation to Nanoform’s Interim Report January-March 2022

Press release Nanoform Finland Plc May 10[th], 2022 11:00 a.m. Finnish time / 10:00 a.m. Swedish time Invitation to Nanoform’s Interim Report January-March 2022 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, will publish its Interim Report January-March 2022 on May 24[th], 2022, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold an online presentation and conference call the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be represented by CEO Edward Hæggström,

Valmet delivers a press technology upgrade to Natron-Hayat Pulp and Paper Mill in Bosnia-Herzegovina

Valmet Oyj’s trade press release May 10, 2022 at 11:00 a.m. EESTNatron-Hayat Pulp and Paper Mill in Maglaj, Bosnia-Herzegovina, has ordered a press technology upgrade from Valmet. The delivery includes two refurbished Twin Roll Presses and additional equipment and services to secure the trouble-free operation of the presses. The order was included in Valmet's orders received of the first quarter 2022. The delivery will be completed in September 2022. The value of the order will not be disclosed. One of Valmet’s TwinRoll Presses will be installed in the pulp mill to increase the

H2 Green Steel has pre-sold over 1.5 million tonnes of green steel to customers

Stockholm, May 10, 2022 – As a clear sign of a strong customer demand for green steel, H2 Green Steel has already signed off-take supply agreements for over 1.5 million tonnes of the volumes it will produce from 2025 onwards.H2 Green Steel has signed customer contracts in different industries of more than 5-7 years for over 1.5 million tonnes per year out of the planned initial yearly production volume of 2.5 million tonnes. “When we launched H2 Green Steel about a year ago, we kicked the transformation of the steel industry into a new gear and other players in the industry have moved up

3 new companies to present at the BioStock Life Science Spring Summit on June 8-9!

On June 8-9, it is finally time for BioStock Life Science Spring Summit 2022, where companies from a wide range of therapeutic areas will present their projects and innovations, in a packed program that also offers valuable insights from investment experts and industry profiles. Today, we reveal three new companies that will present at the Spring Summit!The event will be broadcasted on the BioStock website and on our YouTube channel. You can also access the event through our social media platforms. Today, we reveal three new companies that will present at the BioStock Life Science Spring

BioStock: Unchanged sales figures for Invent Medic in Q1

Invent Medic has started 2022 on the offence, with several new initiatives and focus on increasing sales of the two products in the Efemia family. So far, however, these initiatives have not translated into increased sales, as the sales figures for the first quarter 2022 remained largely unchanged compared to the same period 2021. Looking closer at the numbers, however, the company sees some promising signals, something that BioStock asked about when we contacted CEO Anna Lindström for a comment.Read the full article at biostock.se:https://www.biostock.se/en/2022/05/unchanged-sales-

Lindex highlights its Swedish heritage when launching summer collection with Carl Larsson artwork

Lindex launches a collection featuring the artwork of Carl Larsson, who together with his wife Karin defined their era and is part of the Swedish cultural heritage. A collection of classic summer pieces that tell a part of history, with matching pieces for kids, baby and women. ‘Karin and Carl Larsson were pioneers of their time and their artistic expression has made a mark in the Swedish cultural heritage. We are proud of our Swedish heritage at Lindex and how it defines our focus on design, quality and sustainability. So it felt natural for us to design a summer collection with

Notice to extraordinary general meeting in Bonava AB (publ)

Shareholders of Bonava AB (publ) ("Bonava"), are hereby invited to an extraordinary general meeting, to be held on Thursday 2 June. The extraordinary general meeting will be carried out only through postal voting in accordance with the Act (2022:121) on temporary exceptions to facilitate the execution of general meetings in companies and other associations. It will not be possible to attend the meeting in person or by proxy.   Participation To be entitled to participate at the meeting, a shareholder must: · be listed in the shareholders' register maintained by Euroclear Sweden

Interim Report Q1 2022: Revenue growth of 111%

Company Announcement no. 8/202210 May 2022   The Board of Directors for Wirtek A/S has today approved the interim report for first quarter of 2021 for the Wirtek Group. The detailed interim report for Q1 2021 is attached to this announcement. CEO Michael Aaen comments: “Our strong momentum from 2021 continued in Q1 2022 with solid order intake, positive adjustment of our expectations to 2022 and the release of our updated growth strategy, Accelerate25XL. Revenue grew by 111% the first quarter of 2022 compared to Q1 last year and EBITDA was up 76%, although Wirtek has been

Wyld Networks to base USA operations in Missouri

Wyld Networks to partner with World Trade Center St. Louis and STL Partnership to base Wyld’s USA operations in Missouri to develop satellite IoT for US agriculture and supply chain sectors.Nearly half of the USA’s total agricultural productivity is harvested within a 500-mile radius of St. Louis. Additionally, many of the sector’s major businesses are headquartered in Missouri. Furthermore, St Louis is integral to the US logistics infrastructure having key major highway intersections, rail and air hubs and the confluence of the Mississippi and Missouri rivers. The Missouri Department of

Notice of annual general meeting in Polymer Factory Sweden AB

Shareholders in Polymer Factory Sweden AB, reg. nr 556695-9531 (the “Company”), are hereby summoned to the Annual General Meeting on Wednesday 8 June 2022 through advance voting. Attendance at the meeting is only possible via postal ballot.The Annual General meeting will be executed only through postal voting, in accordance with section 22 of the Act (2022:121) on temporary exceptions to facilitate the execution of general meetings in companies and other associations. This means that shareholders will not be allowed to participate in person or by proxy at the general meeting held on 8 June

NILAR INTERNATIONAL AB INTERIM REPORT Q1 2021

NILAR EXECUTES ON REVISED STRATEGYJanuary – March 2022 in summary · Net sales, MSEK -4.2 (5.4). · Production MWh 0.0 (3.2). · Delivered batteries 52 (992). · Gross profit[1)] MSEK -40.8 (-69.6). · EBITDA MSEK -48,1 (-78.0). · Operating profit (EBIT) MSEK -63.5 (-96.0). · Profit for the period MSEK -74.2 (-114.4). · Earnings per share before/after dilution SEK -1.63 (-22,53). Significant events during the first quarter · Cost savings during the quarter have exceeded management expectations. · The negotiations following the two redundancy notices issued in

Unique Alfa Laval technology recovers industrial waste heat for reuse in Hamburg’s district heating network

Alfa Laval’s specially designed heat exchangers will recover waste heat from a sulphuric acid plant for reuse in district heating in Hamburg, Germany. The initial waste heat recovery process was installed in 2018, and the plant is now expanding the project to provide heating for more approximately 23,000 households, offices, hotels and the university. The project is part of a German government initiative to increase the city’s green footprint.Aurubis Group is a leading global provider of non-ferrous metals and one of the largest copper recyclers worldwide. The related sulphuric acid process

TF Bank: Monthly statistics April 2022

The total loan portfolio amounted to SEK 11,655 million at the end of April. Compared to April 2021, the loan portfolio has increased by 29 % in local currencies.  Month Apr-22 Apr-21 ChangeConsumer Lending   New lending, SEK million 431 350 23 %Ecommerce Solutions   Transaction volume*, SEK million 739 585 26 %Credit Cards   New lending, SEK million 312 147 112 %  Cumulative for the year Jan-Apr 22 Jan-Apr 21 ChangeConsumer Lending   New lending, SEK million 1

Calliditas Therapeutics to participate in upcoming investor conferences

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its management team will participate in the following upcoming investor conferences and events: · The 8[th] Annual LSX World Congress on May 10-11, 2022 in London, United Kingdom · The ABGSC Life Science Summit on May 18–19, 2022, in Stockholm, Sweden. · H.C. Wainwright Hybrid Global Investment Conference on May 23-26, 2022. · Jefferies Healthcare Conference on June 8-10, 2022 in New York City, USA. · Citi European Healthcare Conference on June 14–16, 2022 in London, United

Cary Group commits to the Science Based Targets initiative

Cary Group aims to be an industry leader when it comes to climate action. The company has, as a part of its strategy, set a high and clear objective on how to reduce its climate impact. Therefore, Cary Group commits to the Science Based Targets initiative (SBTi) as a next step to reach its reduction targets in line with the 1,5°C goal of the Paris Agreement by 2030.Cary Group has committed to set targets in line with the Science Based Targets initiative (SBTi), consistent with the Paris Agreement. This is a natural step in Cary Group’s sustainable strategy, which incorporates sustainability

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for April 2022

Hamilton, Bermuda, May 10, 2022   Commercial update: In April 2022, the Company achieved average time charter equivalent earnings of approximately US$23,600 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$20,300 per day, gross, including average daily scrubber benefits of approximately US$1,600 per day. The Company’s two vessels trading on fixed time charter earned approximately US$33,700 per day, gross, including average daily scrubber benefits of approximately US$2,300 per day.   The Baltic 5TC Capesize Index averaged

Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma

· Targovax has entered into an agreement with Oslo University Hospital (OUS) to test TG01 in a phase 1/2 trial in 20 patients with RAS mutant multiple myeloma · The trial will be sponsored by OUS and led by Dr. Fredrik Schjesvold, an international leader in the field and founder of the Oslo Myeloma Center, the largest Myeloma center in the Nordics · The trial will be the first time TG vaccination is tested in patients together with the new adjuvant QS-21 STIMULON™ from collaboration partner AgenusOslo, Norway, 10 May 2022 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology

Interim report January – March 2022

First quarter in brief · Net sales amounted to 9.9 million SEK (14.7), which represents a decrease in sales of 33 percent. · Operating profit amounted to -3.6 million SEK (2.5). · Net profit for the period amounted to -3.5 million SEK (2.7). · Earnings per share amounted to -0.08 SEK (0.07).   Significant events during the first quarter During the period, a directed share issue was carried out for an amount equivalent to 60 million SEK before transaction costs. SyntheticMR US Inc has entered a partnership with Hyland Healthcare. A sales and support

Veg of Lund updates strategy and revises objectives with focus on growth

The Board of Directors of Veg of Lund AB has conducted a strategic review of the business and decided on an updated strategy and revised targets in order to increase sales. The company clarifies that the business model consists of a hybrid between own and licensed production and sales. The strategy is to accelerate sales by appointing licensees in more countries. The goal is to reach a turnover of MSEK 420 with a positive operating result by the year 2025.Veg of Lund’s current board took office after an extraordinary general meeting on 31 January 2022 and has conducted a review of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top